Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 206-114-9 | CAS number: 302-01-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Description of key information
There is no Two-Generation reproductive toxicity study available.
Based on the available information from Reproductive Toxicity Screening
test (OECD TG 421) and data from repeated dose toxicity, there is no
evidence of a specific reproductive toxicity of hydrazine.
Furthermore, hydrazine is classified as a Class 1B Carcinogen and
according to the specific rules (Column 2) of Annex XI of Regulation
(EC)1907/2006 (REACH) further testing for Reproductive Toxicity
(Fertility Assessment or Developmental Toxicity) has not to be
considered.
Effect on fertility: via oral route
- Endpoint conclusion:
- no study available
- Quality of whole database:
- There is no two -generation study available as required for the respective tonnage band. Hydrazine is classified and labelled as carcinogene (Cat2, carcinogen, R45 (R67/548/EEC); Carcinogenicity Class 1B, H350 (Regulation No. 1272/2008(GHS)). Based on the information given in ANNEX IX and X of REACh Regulation no studies need to be available nor to be performed.
In addition, in a Reproductive Toxicity Screening Test according to OECD 421 there was no evidence of a specifc reproductive toxicity of hydrazine monohydrate.
Effect on fertility: via inhalation route
- Endpoint conclusion:
- no study available
Effect on fertility: via dermal route
- Endpoint conclusion:
- no study available
Additional information
There is no two-generation-reproductive toxicity study available.
Hydrazine is classified as a Class 1B Carcinogen and according to the specific rules (Column 2) of Annex XI of Regulation (EC)1907/2006 (REACH) further testing for Reproductive Toxicity (Fertility Assessment or Developmental Toxicity) has not to be considered.
However, in a Reproductive Toxicity Screening Test according to OECD 421 there was no evidence of a specifc reproductive toxicity of hydrazine monohydrate. The NOEL for repeated dose toxicity was 2 mg/kg in that study. There was no effect on fertility index up to the highest dose of 18 mg/kg. In the highest dose of 18 mg/kg, a clearly toxic dose, females could not maintain pregnancy, but there was no respective effect in the next lower dose of 6 mg/kg. Viability index at day 4 as indication of toxicity to the offspring was slightly reduced in the 6 mg/kg group (no effect at 2 mg/kg). In repeated dose toxicity studies there was some evidence of effects on reproductive organs in repeated dose toxicity studies (see section 7.8.3), but respective effects were not obvious in a recent subacute toxicity study (MHWL 2003), which is in line with the result of the Reproductive Toxicity Screening Assay. Therefore. based on the available data there is no reason to expect a specific reproductive toxicity of hydrazine.
As confirmed by recent literature (Mangelsdorf et al 2003, Ulbrich & Palmer 1995, Janer et al 2007a, Dent 2007, Sanbuissho et al. 2009) in rodents histopathological examinations in repeated dose toxicity studies of reproductive tissues are of high value and high sensitivity for evaluation of reproductive toxicity in males and females. Histopathological changes on the reproductive organs in repeated dose toxicity studies are indicative of effects on fertility. With this respect repeated dose toxicity studies should be considered sensitive and sufficient information to evaluate toxicity on fertility if histological examination of the reproductive organs is covered.
Based on the considerations above no further testing is required for the fertility assessment as hydrazine has not shown specific effects on reproductive organs in male and female rats in the lower effect dose range and there was no evidence of a specifc reproductive toxicity of hydrazine monohydrat in a reproductive screening assay.
------
Mangelsdorf. et al., 2003: Some aspects relating to the evaluation of the effects of chemicals on male fertility. Regulatory toxicology and Pharmacology 36, 69-98
Ulbrich & Palmer, 1995: Detection of effects on male reproduction ¿ a literature survey. J am. College of Toxicology 14, 293-327
Janer et al., 2007: A retrospective analysis of the added value of the rat two-generation reproductive toxicity study versus the rat subchronic toxicity study. Reproductive Toxicology 24, 103-113
Dent, 2007: Strength and limitations of using repeated-dose toxicity studies to predict effects on fertility. Regulatory Toxicology and Pharmacology 48, 241-258
Sanbuissho et al., 2009: Collaborative work on evaluation of ovarian toxicity by repeated-dose and fertility studies in female rats. J Tox. Sci. 34:Special Issue SP1-SP22
Short description of key information:
There is no Two-Generation reproductive toxicity study available
Based on the available information from Reproductive Toxicity Screening
test (OECD TG 421) and data from repeated dose toxicity, there is no
evidence of a specific reproductive toxicity of hydrazine.
Furthermore, hydrazine is classified as a Class 1B Carcinogen and
according to the specific rules (Column 2) of Annex XI of Regulation
(EC)1907/2006 (REACH) further testing for Reproductive Toxicity
(Fertility Assessment or Developmental Toxicity) has not to be
considered.
Justification for selection of Effect on fertility via oral route:
There is no two-generation study available as required for the
respective tonnage band. Hydrazine is classified and labelled as
carcinogene (Carcinogenicity Class 1B, H350 (Regulation No.
1272/2008(GHS)). Based on the information given in ANNEX IX and X of
REACH Regulation no studies need to be available nor to be performed.
Effects on developmental toxicity
Description of key information
There is no developmental toxicity study available using a dosing regim
which is relevant for the human situation. Furthermore, hydrazine is
classified as a Class 1B Carcinogen and according to the specific rules
(Column 2) of Annex XI of Regulation (EC)1907/2006 (REACH) further
testing for Reproductive Toxicity (Fertility Assessment or Developmental
Toxicity) has not to be considered
However, pregnant female rats were intraperitoneal injected with 0, 2.5,
5.0, 10.0 mg/kg/d once daily on gd 9 -16 and sacrificed on gd day 20.
The NOAEL (maternal toxicity ) was determined 2.5 mg/kg bw/day; the
NOAEL (developmental toxicity) was determined 2.5 mg/kg bw/day based on
a dose-related embryolethality from 5.0 mg/kg bw/d onwards. Furthermore,
treatmant of dams with 10 mg/kg bw on gd 7-9 resulted in significantly
increased number of resorptions per litter, significantly decreased
fetal body weight and fetal abnormalities including supernumerary ribs,
moderate hydronphrosis and moderate hydrocephalus (Keller 1982).
Effect on developmental toxicity: via oral route
- Endpoint conclusion:
- no study available
Additional information
There is no developmental toxicity study available using a dosing regime which is relevant for the human situation.
However, pregnant female rats were intraperitoneal injected with 0, 2.5, 5.0, 10.0 mg/kg/d once daily on gd 9 -16 and sacrificed on gd day 20. The NOAEL (maternal toxicity ) was determined 2.5 mg/kg bw/day based on reduced weight gain or weight loss during treatment from 5.0 mg/kg bw/d onwards; the NOAEL (developmental toxicity) was determined 2.5 mg/kg bw/day based on a dose-related embryolethality from 5.0 mg/kg bw/d onwards. Furthermore, treatmant of dams with 10 mg/kg bw on gd 7 -9 resulted in significantly increased number of resorptions per litter, significantly decreased fetal body weight and fetal abnormalities including supernumerary ribs, moderate hydronphrosis and moderate hydrocephalus (Keller 1982).
Considering the available study on developmental toxicity in rats developmental toxicity occurs only in the presence of maternal toxicity and mainly at clear toxic dose. Hence, hydrazine was applied as intraperitoneal injection which includes the possibility to hurt the developing organism and on the other hand this application route is not suitable for the human situation. However, regarding the available Reproduction Toxicity Screening Assay (OECD TG 421) using the oral application route, there is no evidence of fetal abnormalities.
Furthermore, hydrazine is classified as a Class 1B Carcinogen and according to the specific rules (Column 2) of Annex X of Regulation (EC)1907/2006 (REACH) further testing for Reproductive Toxicity (Fertility Assessment or Developmental Toxicity) has not to be considered
Justification for selection of Effect on developmental
toxicity: via oral route:
There is no developmental study according to OECD TG 414 available
using using a dose regim which is relevant for the human situation.
Furthermore Hydrazine is classified and labelled as carcinogene
(Carcinogenicity Class 1B, H350 (Regulation No. 1272/2008(GHS)) . Based
on the information given in ANNEX IX and X of REACH Regulation no
further studies need to be available nor to be performed.
Justification for classification or non-classification
The substance is not classified in one of the categories for fertility assessment or developmental toxicity.
Hydrazine has not shown specific effects on reproductive organs in male and female rats in tests with repeated dose toxcicity. Thus, there is no reason for classification.
With regard to developmental toxicity no classification has to be required because developmental effects occur only in the presence of clear maternal toxicity. Thus, the available data are conclusive but not sufficient for classification.
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.